Cargando…

Non-invasive screening for subclinical liver graft injury in adults via donor-specific anti-HLA antibodies

The majority of liver grafts exhibit abnormal histological findings late after transplantation, even when liver enzymes are normal. Such subclinical graft injuries were associated with rejection and fibrosis progression in recent studies. The identification of non-invasive biomarkers for subclinical...

Descripción completa

Detalles Bibliográficos
Autores principales:	Höfer, Anne, Jonigk, Danny, Hartleben, Björn, Verboom, Murielle, Hallensleben, Michael, Manns, Michael P., Jaeckel, Elmar, Taubert, Richard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7455737/ https://www.ncbi.nlm.nih.gov/pubmed/32859929 http://dx.doi.org/10.1038/s41598-020-70938-7

Ejemplares similares

Baseline IL-2 and the AIH score can predict the response to standard therapy in paediatric autoimmune hepatitis
por: Diestelhorst, Jana, et al.
Publicado: (2018)

IgM-Enriched Human Intravenous Immunoglobulin-Based Treatment of Patients With Early Donor Specific Anti-HLA Antibodies After Lung Transplantation
por: Ius, Fabio, et al.
Publicado: (2016)

Association of torque teno virus viremia with liver fibrosis in the first year after liver transplantation
por: Engel, Bastian, et al.
Publicado: (2023)

An Improved Protocol for Targeted Differentiation of Primed Human Induced Pluripotent Stem Cells into HLA-G-Expressing Trophoblasts to Enable the Modeling of Placenta-Related Disorders
por: Shum, Ian O., et al.
Publicado: (2023)

Salvage therapies of autoimmune hepatitis limit proinflammatory immune cells while sparing regulatory T cells
por: Derben, Finn C., et al.
Publicado: (2023)

Hyperferritinemia and hypergammaglobulinemia predict the treatment response to standard therapy in autoimmune hepatitis
por: Taubert, Richard, et al.
Publicado: (2017)

Dulaglutide Alone and in Combination with Empagliflozin Attenuate Inflammatory Pathways and Microbiome Dysbiosis in a Non-Diabetic Mouse Model of NASH
por: Hupa-Breier, Katharina Luise, et al.
Publicado: (2021)

Quantification of extracellular matrix remodeling for the non-invasive identification of graft fibrosis after liver transplantation
por: Engel, Bastian, et al.
Publicado: (2023)

Application of the Liver Maximum Function Capacity Test in Acute Liver Failure: A Helpful Tool for Decision-Making in Liver Transplantation?
por: Vondran, Florian Wolfgang Rudolf, et al.
Publicado: (2016)

Pediatric autoimmune hepatitis shows a disproportionate decline of regulatory T cells in the liver and of IL-2 in the blood of patients undergoing therapy
por: Diestelhorst, Jana, et al.
Publicado: (2017)

Preemptive treatment of early donor‐specific antibodies with IgA‐ and IgM‐enriched intravenous human immunoglobulins in lung transplantation
por: Ius, Fabio, et al.
Publicado: (2018)

Preformed Donor-specific Antibodies Against HLA Class II and Graft Outcomes in Deceased-donor Kidney Transplantation
por: Uffing, Audrey, et al.
Publicado: (2019)

No association of serum ferritin levels with advanced liver fibrosis in untreated German patients with autoimmune hepatitis
por: Engel, Bastian, et al.
Publicado: (2022)

Association of non-HLA antibodies against endothelial targets and donor-specific HLA antibodies with antibody-mediated rejection and graft function in pediatric kidney transplant recipients
por: Fichtner, Alexander, et al.
Publicado: (2021)

Donor Specific Anti-HLA Antibody and Risk of Graft Failure in Haploidentical Stem Cell Transplantation
por: Kongtim, Piyanuch, et al.
Publicado: (2016)

Phosphorylation of S6RP in peritubular capillaries of kidney grafts and circulating HLA donor-specific antibodies
por: Raïch-Regué, Dalia, et al.
Publicado: (2022)

Donor–specific HLA-DQ antibodies may contribute to poor graft outcome after heart transplantation
por: Omrani, Osama, et al.
Publicado: (2018)

Pretransplant Donor-Specific Anti-HLA Antibodies and the Risk for Rejection-Related Graft Failure of Kidney Allografts
por: Betjes, Michiel G. H., et al.
Publicado: (2020)

Hypercortisolaemia due to ectopic adrenocorticotropic hormone secretion by a nasal paraganglioma: a case report and review of the literature
por: Thomas, Theodoros, et al.
Publicado: (2013)

Evaluation of immunoserological detection of anti-liver kidney microsomal, anti-soluble liver antigen and anti-mitochondrial antibodies
por: Campos-Murguia, Alejandro, et al.
Publicado: (2023)

Nonimmunologic Donor-Recipient Pairing, HLA Matching, and Graft Loss in Deceased Donor Kidney Transplantation
por: Vinson, Amanda Jean, et al.
Publicado: (2018)

Increased seroprevalence of HAV and parvovirus B19 in children and of HEV in adults at diagnosis of autoimmune hepatitis
por: Taubert, Richard, et al.
Publicado: (2018)

Differential effects of donor‐specific HLA antibodies in living versus deceased donor transplant
por: Kamburova, E. G., et al.
Publicado: (2018)

Donor specific HLA antibody in hematopoietic stem cell transplantation: Implications for donor selection
por: Krummey, Scott M., et al.
Publicado: (2022)

T-Cell Epitopes Shared Between Immunizing HLA and Donor HLA Associate With Graft Failure After Kidney Transplantation
por: Peereboom, Emma T. M., et al.
Publicado: (2021)

Post-transplant donor-specific anti-HLA antibodies with a higher mean fluorescence intensity are associated with graft fibrosis in pediatric living donor liver transplantation
por: Goto, Ryoichi, et al.
Publicado: (2023)

SARS-CoV-2-specific immunity in immunosuppressed COVID-19 convalescents with autoimmune hepatitis
por: Kirchner, Theresa, et al.
Publicado: (2021)

Living Donor Kidney Transplantation in Patients With Donor-Specific HLA Antibodies After Desensitization With Immunoadsorption
por: Kälble, Florian, et al.
Publicado: (2021)

Increased apoptosis of regulatory T cells in patients with active autoimmune hepatitis
por: John, Katharina, et al.
Publicado: (2017)

HLA discrepancy between graft and host rather than that graft and first donor impact the second transplant outcome
por: Maeda, Yoshinobu, et al.
Publicado: (2019)

Donor-specific anti-HLA antibodies in unrelated hematopoietic cell transplantation for non-malignant disorders
por: Woolfrey, Ann, et al.
Publicado: (2018)

HLA class II donor specific antibodies are associated with graft cirrhosis after liver transplant independent of the mean fluorescence intensity level
por: Willuweit, Katharina, et al.
Publicado: (2020)

Impact of Donor-Specific anti-HLA Antibodies and Donor KIR Characteristics in Haploidentical HSCT for Beta-Thalassemia
por: Andreani, Marco, et al.
Publicado: (2017)

Behaviour of Non-Donor Specific Antibodies during Rapid Re-Synthesis of Donor Specific HLA Antibodies after Antibody Incompatible Renal Transplantation
por: Krishnan, Nithya S., et al.
Publicado: (2013)

Cytokine Profiles in Children After Pediatric Kidney Transplantation With Acute Cellular Compared to Chronic Antibody-mediated Rejection and Stable Patients: A Pilot Study
por: Borsum, Nadja, et al.
Publicado: (2019)

An adjustable predictive score of graft survival in kidney transplant patients and the levels of risk linked to de novo donor-specific anti-HLA antibodies
por: Prémaud, Aurélie, et al.
Publicado: (2017)

Donor-Specific Anti-HLA Antibodies in Allogeneic Hematopoietic Stem Cell Transplantation
por: Morin-Zorman, Sarah, et al.
Publicado: (2016)

Daratumumab for donor-specific anti-HLA antibody desensitization in a case of HLA-mismatched allogeneic stem cell transplantation
por: Ibrahim, Uroosa, et al.
Publicado: (2023)

HLA Antibody Rates Are Not Increased in a Regional Group of Male COVID-19 Convalescent Plasma Donors
por: Juskewitch, Justin E., et al.
Publicado: (2021)

Impact of preformed donor-specific antibodies against HLA class I on kidney graft outcomes: Comparative analysis of exclusively anti-Cw vs anti-A and/or -B antibodies
por: Santos, Sofia, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_i7jnoui5ivjrrtksvb7n5v0r8g